Dual-Pronged Lipid Nanocarriers Promote Immunotherapy for TNBC by Inducing Immunogenic Cell Death and Activating Lymphoid Immune Cells

作者
Jun Ye,Shiyuan Wang,Siyi Wu,Renjie Li,Xiang Li,Shan Chen,Yujie Wang,Lu Wang,Caiyun Qin,Hongliang Wang,Yanfang Yang,Jiani Wang,Tingting Du,Fei Ma,Yuling Liu
出处
期刊:Research [American Association for the Advancement of Science]
卷期号:9: 1139-1139 被引量:5
标识
DOI:10.34133/research.1139
摘要

Triple-negative breast cancer (TNBC) is recognized as the notoriously difficult molecular subtype of breast cancer to manage therapeutically, creating a pressing need for more effective treatment approaches. Immunochemotherapy is an emerging strategy with great clinical potential, but most focus on the tumor microenvironment itself and ignore the immune regulation of lymph nodes. Herewith, we report a dual-pronged approach of tumor-targeted paclitaxel-encapsulated nanoemulsion (PTX Emul, Phase II clinical trial) and lymph node-targeted chlorogenic acid-encapsulated self-emulsifying nanocarriers (CHA-SME) to elicit strong and selective immunogenic cell death (ICD) in the tumor and to activate immune cells in the lymph nodes, respectively, to achieve highly effective cancer immunotherapy. PTX Emul exhibited evident tumor targetability and superior tumor accumulation, induced potent ICD, and then efficiently stimulated the maturation of dendritic cells (DCs). CHA-SME demonstrates a substantial capacity to enhance drug accumulation within the mesenteric lymph nodes through the lymphatic transport pathway. Of note, PTX Emul combined with CHA-SME augmented the immunotherapeutic effects through highly efficient ICD induction within the tumor microenvironment of 4T1 orthotopic tumor, the potent DC maturation, and the effective activation of T cell-based antitumor immunity, resulting in a substantial enhancement in the inhibition of 4T1 orthotopic tumors and, notably, a reduction in lung metastasis. The dual-pronged approach of TNBC-targeted PTX Emul and lymph node-targeted CHA-SME by inducing ICD and activating lymphoid immune cells, which amplifies the systemic antitumor immune response, provides an interesting platform for potent immunochemotherapy of TNBC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.2的应助被齐云山采纳,获得10
1秒前
满意哈密瓜,数据线完成签到,获得积分10
1秒前
1秒前
伊莎贝儿发布了新的文献求助10
1秒前
weeqe发布了新的文献求助10
2秒前
希望天下0贩的0的应助被nnn采纳,获得10
2秒前
100毫升完成签到 ,获得积分10
2秒前
3秒前
细心觅风发布了新的文献求助10
3秒前
希望天下0贩的0的应助被wxnice采纳,获得10
3秒前
shangguang发布了新的文献求助10
4秒前
郗XI发布了新的文献求助10
4秒前
FashionBoy的应助被罐装采纳,获得10
5秒前
江江完成签到,获得积分10
6秒前
NexusExplorer的应助被竹马子采纳,获得10
7秒前
viauue9完成签到,获得积分10
8秒前
8秒前
9秒前
倒计时发布了新的文献求助10
9秒前
伊莎贝儿完成签到,获得积分10
9秒前
ljy完成签到,获得积分20
10秒前
爱听歌完成签到,获得积分10
10秒前
jiangyang完成签到,获得积分10
10秒前
OVO关注了科研通微信公众号
11秒前
12秒前
12秒前
12秒前
12秒前
12秒前
14秒前
znn发布了新的文献求助10
14秒前
fay1987完成签到,获得积分10
15秒前
15秒前
yy完成签到,获得积分10
15秒前
泡泡完成签到,获得积分20
15秒前
彻底完成签到,获得积分10
16秒前
你好纠结伦完成签到,获得积分10
16秒前
香瓜完成签到,获得积分10
16秒前
Owen的应助被安格大大大采纳,获得10
16秒前
Feng发布了新的文献求助10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8168144
求助须知:如何正确求助?哪些是违规求助? 9561199
关于积分的说明 21759542
捐赠科研通 7759434
什么是DOI,文献DOI怎么找? 3429948
关于科研通互助平台的介绍 2553742
邀请新用户注册赠送积分活动 2474463